Top compounds associated with response to EIF2S2


Feature Type Standardized
Nominal ANOVA
mRNA PFI-1 GDSC1000 pan-cancer AAC 0.012 0.7
mRNA CHEMBL374350 CTRPv2 pan-cancer AAC -0.013 0.7
mRNA SU11274 CTRPv2 pan-cancer AAC -0.012 0.7
mRNA ML334 diastereomer CTRPv2 pan-cancer AAC -0.016 0.7
mRNA tivozanib GDSC1000 pan-cancer AAC 0.012 0.7
mRNA Erlotinib gCSI pan-cancer AAC 0.02 0.7
mRNA BRD-K63431240 CTRPv2 pan-cancer AAC -0.012 0.7
mRNA Gefitinib FIMM pan-cancer AAC -0.055 0.7
mRNA procarbazine CTRPv2 pan-cancer AAC 0.013 0.7
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.011 0.7
Download CSV